Physiological Intermolecular Modification Spectroscopy for the Prediction of Response to Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Diseases

Digestive Diseases - Switzerland
doi 10.1159/000358151
Full Text
Abstract

Available in full text

Date
Authors
Publisher

S. Karger AG

Related search

Rapid Response to Vedolizumab Therapy in Biologic-Naïve Patients With Inflammatory Bowel Diseases

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Tumor Necrosis Factor Alpha in Inflammatory Bowel Disease.

Gut
Gastroenterology
1994English

Review Article: Consensus Statements on Therapeutic Drug Monitoring of Anti-Tumour Necrosis Factor Therapy in Inflammatory Bowel Diseases

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Prevalence and Pathogenesis of Anemia in Inflammatory Bowel Disease. Influence of Anti-Tumor Necrosis Factor- Treatment

Haematologica
Hematology
2009English

Editorial: CT-P13, a Biosimilar of Anti-Tumour Necrosis Factor-Alpha Agent (Infliximab), in Inflammatory Bowel Diseases

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Pgi42 - Non-Persistence With Immunosuppresant, Anti-Tumor Necrosis Factor, and Anti-Integrin Agents in Patients With Inflammatory Bowel Disease: A Retrospective Claims Data Analysis in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Prediction of Low Bone Mineral Density in Patients With Inflammatory Bowel Diseases

United European Gastroenterology Journal
OncologyGastroenterology
2016English

Serological Markers in Diagnosis of Pediatric Inflammatory Bowel Disease and as Predictors for Early Tumor Necrosis Factor Blocker Therapy

Scandinavian Journal of Gastroenterology
Gastroenterology
2016English

The Tumor Necrosis Factor Superfamily of Cytokines in the Inflammatory Myopathies: Potential Targets for Therapy

Clinical and Developmental Immunology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy